ANALYSIS OF HUMAN ANTIVIRAL CYTOTOXIC T-LYMPHOCYTE RESPONSES FOR VACCINE TRIALS USING CRYOPRESERVED MONONUCLEAR LEUKOCYTES - DEMONSTRATION OF FEASIBILITY WITH INFLUENZA VIRUS-SPECIFIC RESPONSES

被引:4
作者
ELDAHER, N [1 ]
NICHOLS, JE [1 ]
ROBERTS, NJ [1 ]
机构
[1] UNIV ROCHESTER,MED CTR,SCH MED,DEPT MED,INFECT DIS UNIT,ROCHESTER,NY 14642
关键词
D O I
10.1128/CDLI.1.5.487-492.1994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The feasibility of measuring virus-specific human cytotoxic T-lymphocyte (CTL) activity by using cryopreserved mononuclear leukocytes to support clinical vaccine trials was addressed. Autologous fresh and cryopreserved cells from the same sample of peripheral blood were used as sources of CTL precursors and were tested for influenza virus-specific activity. The data indicated that virus-specific CTL activity could be measured by using cryopreserved cells; this could also be done in assays that are designed to characterize the responsible effector cell population.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 24 条
[1]  
BIDDISON WE, 1980, J IMMUNOL, V124, P548
[2]  
BIDDISON WE, 1979, J IMMUNOL, V122, P1705
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]  
COLLINS DS, 1992, J IMMUNOL, V148, P3336
[5]  
ELDAHER N, 1993, J INFECT DIS, V168, P306, DOI 10.1093/infdis/168.2.306
[6]  
ELDAHER N, UNPUB
[7]  
ENNIS FA, 1981, LANCET, V2, P887
[8]   A NEW PORTABLE DEVICE FOR AUTOMATIC CONTROLLED-GRADIENT CRYOPRESERVATION OF BLOOD MONONUCLEAR-CELLS [J].
HVIID, L ;
ALBECK, G ;
HANSEN, B ;
THEANDER, TG ;
TALBOT, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) :135-142
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS [J].
KEEFER, MC ;
BONNEZ, W ;
ROBERTS, NJ ;
DOLIN, R ;
REICHMAN, RC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :448-453
[10]   INDUCTION OF CD8+ CYTOTOXIC T-CELLS BY IMMUNIZATION WITH KILLED INFLUENZA-VIRUS AND EFFECT OF CHOLERA-TOXIN B-SUBUNIT [J].
MBAWUIKE, IN ;
WYDE, PR .
VACCINE, 1993, 11 (12) :1205-1213